Literature DB >> 11027498

Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene.

Q Wang1, Y Ji, X Wang, B M Evers.   

Abstract

TRAIL, a novel member of the TNF family, acts through membrane receptors to induce apoptosis of activated T lymphocytes and may represent a mechanism for the "immune escape" of certain cancers. Various cytokines appear to increase expression of other TNF family members; however, the regulation of TRAIL has not been defined. The purpose of this study was to assess molecular mechanisms regulating TRAIL gene expression in human colon cancers. In this study, we have cloned the human TRAIL (hTRAIL) promoter ( approximately 1.6 kb) and identified a number of putative transcription factor binding sites such as NFAT, AP-1 and Sp1 sequences which are important for the expression of other TNF family members. Transient transfections of 5'-deletion promoter constructs into either Caco-2 or HT29 colon cancer cells identified TRAIL promoter regions critical for both basal and interferon-gamma (IFN-gamma)-mediated induction. Furthermore, induction of TRAIL mRNA levels was demonstrated in HT29 and Caco-2 cells with IFN-gamma treatment suggesting an important role for this cytokine in TRAIL expression. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027498     DOI: 10.1006/bbrc.2000.3512

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways.

Authors:  Chiung-Hua Huang; Jih-Hwa Guh; Grace Shiahuy Chen; Pin-Hsuan Lu; Ji-Wang Chern
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-06-08       Impact factor: 3.000

2.  Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors.

Authors:  Bruno K Robbs; Andre L S Cruz; Miriam B F Werneck; Giuliana P Mognol; João P B Viola
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

3.  Identification of TRAIL as an interferon regulatory factor 3 transcriptional target.

Authors:  Jessica R Kirshner; Alla Y Karpova; Maren Kops; Peter M Howley
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Macrophage Elastase Induces TRAIL-mediated Tumor Cell Death through Its Carboxy-Terminal Domain.

Authors:  Nadine Dandachi; Neil J Kelly; John P Wood; Christine L Burton; Josiah E Radder; Adriana S Leme; Alyssa D Gregory; Steven D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  2017-08-01       Impact factor: 21.405

Review 5.  Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.

Authors:  Nor Saadah M Azahri; Mary M Kavurma
Journal:  Cell Mol Life Sci       Date:  2013-01-18       Impact factor: 9.261

6.  Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression.

Authors:  Vladimir N Ivanov; Tom K Hei
Journal:  Exp Cell Res       Date:  2006-09-28       Impact factor: 3.905

7.  Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL.

Authors:  Nicole Clarke; Ana M Jimenez-Lara; Emilie Voltz; Hinrich Gronemeyer
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

8.  sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease.

Authors:  Xiaohua Yan; Liyun Xu; Jianni Qi; Xiaohong Liang; Chunhong Ma; Chun Guo; Lining Zhang; Wensheng Sun; Jiyun Zhang; Xiaoyi Wei; Lifen Gao
Journal:  Immunogenetics       Date:  2009-07-23       Impact factor: 2.846

9.  Sp1-mediated TRAIL induction in chemosensitization.

Authors:  Jing Xu; Jun-Ying Zhou; Wei-Zen Wei; Sjaak Philipsen; Gen Sheng Wu
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

10.  Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor.

Authors:  Saghi Ghaffari; Zainab Jagani; Claire Kitidis; Harvey F Lodish; Roya Khosravi-Far
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.